What is the dose of Domperidone (Motilium) for increasing milk supply in lactating women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Domperidone should be prescribed at a dose of 10 mg three times daily to increase milk supply in lactating women, as this dose has been shown to be effective in increasing milk production with minimal side effects, as demonstrated in the most recent and highest quality study 1.

Key Considerations

  • The medication usually takes 3-7 days to show initial effects, with maximum benefit often seen after 2-4 weeks of consistent use.
  • Treatment duration varies but commonly ranges from 3-8 weeks, with some women requiring longer courses.
  • Domperidone works by blocking dopamine receptors, which increases prolactin levels and subsequently enhances milk production.
  • When discontinuing, the dose should be gradually tapered rather than stopped abruptly to prevent sudden drops in milk supply.
  • Common side effects include headache, dry mouth, and abdominal cramps.

Important Notes

  • It's essential to note that domperidone is not FDA-approved in the United States for any indication, though it's used in many other countries for lactation support.
  • Before starting domperidone, other non-pharmacological approaches should be tried first, including frequent breastfeeding, proper latch techniques, breast compression, and adequate hydration and nutrition.
  • A systematic review and meta-analysis 2 also supports the use of domperidone in breastfeeding women with low milk supply, particularly in those with preterm infants.
  • However, the FDA has cautioned against the use of domperidone due to potential cardiac risks, including QT prolongation, cardiac arrest, and sudden death, as highlighted in a commentary 3.

References

Research

Effect of Domperidone on Breast Milk Production in Mothers of Sick Neonates: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine, 2021

Research

Efficacy and Safety of Domperidone and Metoclopramide in Breastfeeding: A Systematic Review and Meta-Analysis.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.